A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...
Transplanting dopamine-releasing neurons into the brain is a promising regenerative therapy for Parkinson’s disease. Two clinical trials show that it is safe, but more evidence is needed to prove its ...
CT perfusion and angiography failed to meet sensitivity and specificity thresholds to determine brain death. Neither should be used as standalone tests to establish death by neurologic criteria, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results